Dr Kim Sweeny specialises in the strategic analysis, assessment and development of innovation. He has participated in a wide range of projects in pharmaceuticals and healthcare, biotechnology, and nanotechnology.

He is engaged in long-term research on the pharmaceuticals, healthcare and the biotechnology industry in Australia and internationally, particularly in terms of the impact of regulatory and other influences on pharmaceutical pricing and demand.

Areas of expertise

  • Assessment & development of new technology & innovation
  • strategic analysis

Contact details

+61 (3) 9919 1349
+61 (3) 9919 1350

Key publications

Journal articles

Sweeny, K., Friedman, H.S., Sheehan, P., Fridman, M. and Shi, H. 2019, A health-system based investment case for adolescent health. Journal of Adolescent Health, 65(1), (S8-S15)

Bertram, M.Y., Sweeny, K., Lauer, J.A., Chisholm, D., Sheehan, P., Rasmussen, B., Upreti, S.R., Dixit, L.P., George, K. and Deane, S. (2018), ‘Investing in non-communicable diseases: An estimation of the return on investment for prevention and treatment services’, Lancet, 4 April 2018

Patton, G.C., Olsson, C.A., Skirbekk, V., Saffery, R., Wlodek, M.E., Azzopardi, P.S., Stonawski, M., Rasmussen, B., Spry, E., Francis, K., Bhutta, Z.A., Kassebaum, N.J., Mokdad, A.H., Murray, C.J.L., Prentice, A.M., Reavley, N., Sheehan, P., Sweeny, K., Viner, R.M., Sawyer, S.M. (2018), ‘Adolescence and the next generation’, Nature, vol. 554, pp. 458-467

Sheehan, P., Sweeny, K., Rasmussen, R., Wils, A., Friedman, H.S., Mahon, J., Patton, G.C., Sawyer, S.M., Howard, E., Symons, J., Stenberg, K., Chalasani, S., Maharaj, N., Reavley, N., Shi, H., Fridman, M., Welsh, A., Nsofor, E. and Laski, L. (2017) 'Building the foundations for sustainable development: A case for global investment in the capabilities of adolescents', The Lancet, online 19 April 2017

Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P. and Saxena, S. (2016) 'Scaling-up treatment of depression and anxiety: A global return on investment analysis', Lancet Psychiatry, vol. 3, no. 5, pp. 415-424

Ten Hoppe-Bender, P., Stenberg, K. and Sweeny, K. (2016), ‘Reductions in stillbirths: More than a triple return on investment’, The Lancet, published online January 18, 2016, S0140-6736(15)01277

Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A.M., Temmerman, M., Mason, E., Friedman, H.S., Bhutta, Z.A., Lawn, J.E., Sweeny, K., Tulloch, J., Hansen, P., Chopra, M., Gupta, A., Vogel, J.P., Ostergren, M., Rasmussen, B., Levin, C., Boyle, C., Kuruvilla, S., Koblinsky, M., Walker, N., de Francisco, A., Novcic, N., Presern, C., Jamison, D. and Bustreo, F. on behalf of the Study Group for the Global Investment Framework for Women’s Children’s Health (2014), ‘Advancing social and economic development by investing in women's and children's health: A new global investment framework’, The Lancet, 19 November, doi:10.1016/S0140-6736(13)62231-X.

Sweeny, K. (2009), ‘The impact of copayments and safety nets on PBS expenditure’, Australian Health Review, 33(2) 215-230.

View more of Dr Sweeny's publications in VU's Research Repository.